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Abstract
Aims/hypothesis. Currently, three categories of mea-
sures are used to assess cardiovascular autonomic
dysfunction: measures of the Ewing-test, measures
of heart-rate variability, and measures of baroreflex
sensitivity. We studied the determinants of these mea-
sures obtained from cardiovascular autonomic func-
tion tests in the Hoorn Study.
Methods. The study group (n = 631) consisted of a
glucose-tolerance-stratified sample from a 50- to 75-
year-old group of people. Cardiac cycle duration
(RR interval) and continuous finger arterial pressure
were measured under three conditions: during (a)
spontaneous breathing, (b) six deep breaths over
one minute, and (c) an active change in position
from lying to standing. From these readings, ten mea-
sures of autonomic function were assessed (three
Ewing, six heart-rate variability and one baroreflex
sensitivity). As possible determinants we considered
age, sex, glucose tolerance, cardiovascular disease,
use of anti-hypertensive drugs, anthropometric fac-
tors, metabolic factors and lifestyle factors.
Results. Multivariate analysis showed that eight of ten
cardiovascular autonomic function measures were
most strongly associated with glucose tolerance. Fur-
thermore, measures were moderately associated
with age, sex, waist-to-hip ratio, use of anti-hyperten-
sive drugs, and insulin. The measures were weakly as-
sociated with coronary artery disease but not with lip-
ids. The strongest determinants seemed to differ be-
tween subjects with and without diabetes: in the
non-diabetic subjects the most strongly associated
were age and use of anti-hypertensive drugs and in
subjects with diabetes, insulin. No consistent differ-
ences in association between the three categories of
measures were observed.
Conclusion/interpretation. The strongest determi-
nants of autonomic function were age, presence of di-
abetes and use of anti-hypertensive drugs. [Dia-
betologia (2000) 43: 561±570]
Keywords Aging, baroreflex, Type II diabetes melli-
tus, cardiovascular disease, glucose intolerance,
heart-rate variability, hypertension, lifestyle, auto-
nomic nervous system, obesity.
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Abbreviations: BRS, Baroreflex sensitivity (ms/mmHg); DM,
diabetes mellitus; EI difference, expiration-inspiration differ-
ence in RR intervals during breathing at 6/min (ms); HRV,
heart-rate variability; HF power, high frequency power in the
RR-interval spectrum between 0.12±0.40 Hz (ms2); KDM,
known diabetes mellitus; LF power, low frequency power in
the RR-interval spectrum between 0.04±0.12 Hz (ms2); LF/
(LF + HF), ratio of low frequency power to the sum of low
and high frequency power in the RR-interval spectrum; Mean
NN, mean of all sinus rhythm (normal-to-normal) RR inter-
vals (ms); NDM, newly-diagnosed diabetes mellitus; RRmax,
maximal change in RR interval after standing up (ms);
RRmax/min, maximal RR interval between 15 s and 30 s after
standing up divided by the minimal RR interval within 15 s af-
ter standing up; SBP difference, systolic blood pressure
1.5±2 min after standing up minus systolic blood pressure in su-
pine position (mmHg); SDNN, standard deviation of all sinus
rhythm (normal-to-normal) RR intervals (ms).
Standard cardiovascular autonomic function tests,
such as the deep breathing test, the lying-to-standing
test, the Valsalva manoeuvre and the sustained hand-
grip test, also known as the `Ewing battery', still are
the corner-stones for the diagnosis of diabetic cardio-
vascular autonomic neuropathy [1±3]. During the last
decade, other measures have come into use, notably
heart-rate variability (HRV) and baroreflex sensitivi-
ty (BRS) [4, 5]. Besides their application in the as-
sessment of cardiovascular autonomic function in di-
abetic patients, these new measures have been intro-
duced in cardiology for risk stratification after myo-
cardial infarction. Low HRV is associated with mor-
tality risk in post-myocardial infarction patients [6,
7] and also in the general population [8, 9].
Diabetic patients have lower values of the Ewing
battery [1], of the spectral analysis of HRV [10, 11],
and have a low BRS [5, 12] in comparison with nor-
mal glucose tolerant control subjects. Besides diabe-
tes, many other factors possibly influence the out-
come of cardiovascular autonomic function tests, in-
cluding age [13±15], sex [16], anthropometric factors
[17], cardiovascular disease [18, 19], use of anti-hy-
pertensive drugs [20, 21], metabolic factors [22±24],
and lifestyle [25, 26]. Since most of these associations
have been described in persons without diabetes, it is
not known to what extent such factors contribute to
the severity of autonomic dysfunction in diabetic sub-
jects. Furthermore, the strength of the relation be-
tween several risk factors (serum cholesterol, systolic
blood pressure and cigarette smoking) and death
from cardiovascular origin has been reported to be
significantly modified (i. e. stronger) by diabetes in
the Multiple Risk Factor Intervention Trial (MRFIT)
[27]. Therefore, it is of interest to study the possibility
of effect-modification by glucose tolerance on the as-
sociations of cardiovascular autonomic function with
the determinants identified in the non-diabetic do-
main.
Qualitative and quantitative knowledge about the
association between test measures and the putative
determinants is useful for pathological conceptualisa-
tion and possibly also for clinical practice. Although
various determinants have been studied separately,
the effect of these factors together, and on a variety
of autonomic function measures, to our knowledge
has not been established in relation to glucose intoler-
ance. We studied this in the Hoorn Study in which we
investigated 50- to 75-year-old Caucasian subjects.
Subjects and methods
Design and study group. This study is part of the Hoorn Study,
a prospective study on glucose tolerance and other cardiovas-
cular risk factors in a 50- to 75-year-old cohort [28]. The base-
line examination was carried out from October 1989 until Feb-
ruary 1992, as previously described in detail [29]. Briefly, a ran-
dom sample of all men and women born between 1914 and
1940 was drawn from the municipal population of the town of
Hoorn, the Netherlands; 2484 persons participated (71 %).
All subjects had a 75-g oral glucose tolerance test (OGTT), ex-
cept those diagnosed previously with diabetes, as indicated by
treatment with oral glucose-lowering drugs or insulin. Strati-
fied by the 2-h glucose concentrations of the first test, age and
sex, 708 subjects were invited for extensive examinations of di-
abetes-related complications. Of this sample 631 (89%) partic-
ipated and thus became the study group. The study protocol
was approved by the ethics committee of the University Hospi-
tal of the Vrije Universiteit. All study participants gave their
informed consent.
Putative determinants. Fasting and 2-h post-load venous plas-
ma glucose concentrations were determined with a glucose de-
hydrogenase method (Merck, Darmstadt, Germany). Subjects
were classified into glucose tolerance groups according to the
criteria of the World Health Organization (WHO), based on
the mean values of two OGTTs, 3 to 5 weeks apart from each
other [30]. We established that 288 subjects had normal glu-
cose tolerance (NGT), 169 had impaired glucose tolerance
(IGT), 95 had newly diagnosed diabetes (NDM), and 79 sub-
jects were known Type II (non-insulin-dependent) diabetic pa-
tients (KDM) as defined by the use of a diet, oral glucose-low-
ering drugs or insulin.
Glycated haemoglobin (HbA1c) was determined by ion-ex-
change high-performance liquid chromatography, using a
Modular Diabetes Monitoring System (Bio-Rad, Veenendaal,
The Netherlands).
Height, weight and body circumferences were measured on
all subjects barefoot and wearing only light clothing. Body
mass index (BMI, kg/m2) was calculated as weight divided by
height squared. Waist-to-hip ratio (WHR) was defined as waist
circumference divided by hip circumference.
Cardiovascular disease was defined as coronary artery,
cerebrovascular or peripheral arterial disease. The self-report-
ed cardiovascular disease history was obtained by means of a
questionnaire. Subjects were asked whether they had received
any medical care during the past 10 years and, if so, for what
reason and from which specialty. The history of macrovascular
disease (myocardial infarction, angina pectoris, intermittent
claudication, transient ischemic attack, or stroke) was assessed
by means of a Dutch translation of the Rose questionnaire
[31]. Furthermore, the names of the drugs and dosages pre-
scribed were recorded. Coronary artery disease was defined
as a self-reported history of myocardial infarction, self-report-
ed angina pectoris, use of nitrates, coronary artery bypass
grafting or Minnesota codes 1±1 or 1±2 on the ECG. Peripher-
al arterial disease was defined as a self-reported peripheral ar-
terial reconstruction, self-reported intermittent claudication,
non-traumatic limb amputation, an ankle brachial pressure in-
dex (ABPI) less than 0.90 or a monophasic/absent flow curve
in the left or right leg arteries as assessed by Doppler flow ve-
locity measurements [32]. The ABPI was obtained by means
of Doppler-assisted systolic blood pressure measurements tak-
en from the brachial and the three crural arteries on both sides
as described previously in more detail [32]. The lowest ABPI
of either limb was used for statistical analysis. Cerebrovascular
disease was defined as a self-reported history of transient is-
chaemic attack, stroke or a carotid stenosis greater than 80 %
as assessed by ultrasonographic examination of both common,
internal and external carotid arteries, done by means of a col-
our-coded Duplex-Doppler scanner (Acuson 128, Mountain
View, Calif., USA). We classified subjects into two categories
on the basis of the maximum percentage of stenosis of the
more diseased of the two carotid arteries: 0 to 80 % or 81 to
100 %.
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Use of anti-hypertensive drugs was defined as current treat-
ment with alpha blockers, beta blockers, calcium antagonists,
angiotensin converting enzyme inhibitors, diuretics, and/or
centrally acting anti-hypertensive drugs.
Blood pressure was measured twice on two occasions on
the right arm of seated subjects after they had rested for at
least 5 min, by means of a random zero mercury sphygmoma-
nometre (Hawksley-Gelman, Lancing, Sussex, UK). The aver-
age of the four readings of systolic (SBP) and diastolic blood
pressure (DBP) (Korotkov V) was calculated. Hypertension
on the basis of blood pressure was thus defined as a SBP of
160 mmHg or higher and/or a DBP of 95 mmHg or higher. Fur-
thermore, hypertension according to the World Health Orga-
nization was defined as use of anti-hypertensive drugs or hy-
pertension on the basis of blood pressure or both.
Fasting specific serum insulin concentrations were quanti-
fied with an insulin specific double antibody radioimmunoas-
say (antibody: Linco SP21, St. Louis, Mo., USA), without
cross-reactivity with proinsulin or split proinsulin.
Concentrations of serum lipids were determined in the fast-
ing blood sample of all subjects. Total cholesterol, HDL cho-
lesterol and triglycerides were measured by an enzymatic pro-
cedure (Boehringer-Mannheim, Mannheim, Germany).
The information on lifestyle variables was obtained by
means of questionnaires. Physical activity was calculated as
the number of positive answers to nine questions concerning
activity (e. g. cycling, walking staircases). Cigarette smoking
and alcohol consumption were expressed on a dichotomized
scale: current smokers, current alcohol consumers vs non-us-
ers.
Cardiovascular autonomic function tests. For the assessment of
cardiovascular autonomic function, participants were asked to
refrain from smoking and drinking coffee for 2 h prior to the
visit to the research centre. Tests were done between 0830
and 1600 hours at least 1 h after a light meal. A quiet setting
was ensured, with a room temperature between 19 and 22 °C.
All tests on all subjects were carried out by a single investiga-
tor who was blinded to the glucose tolerance status. Cardiac
cycle duration (RR interval) and continuous finger arterial
pressure were measured under three conditions: (a) during
spontaneous breathing over 3 min in the supine position, (b)
during six deep breaths over 1 min in the supine position, and
(c) during an active change in position from lying to standing.
The frequency of breathing at six breaths per min was dictated
by the investigator. When off-line spectral analysis showed that
breathing was not done at the appropriate frequency, the re-
cord was discarded. The test session started with a resting peri-
od of at least 10 min, and each separate test started with a rest-
ing period of at least 1 min. During the tests, RR intervals and
blood pressure were continuously recorded on a PC-based
data-acquisition system. We obtained RR intervals from an
electrocardiogram by a hardware QRS detector with an accu-
racy of one millisecond. Blood pressure was recorded using
the Finapres method (Finger Arterial Blood Pressure, Ohme-
da BP2000, Englewood, Colo., USA). We obtained SBP values
from the 200 Hz sampled continuous blood pressure signal by
means of an automatic procedure, which was verified by visual
inspection.
Individual data were missing for the following reasons: the
test schedule was not completed, the quality of the data was in-
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Table 1. Overview of the ten cardiovascular autonomic functions measures classified into three categories according to involve-







During spontaneous breathing over three minutes in supine position
Mean NN The mean of all normal to normal, i. e. sinus rhythm,
RR intervals [33]
+ +
SDNN The standard deviation of all normal to normal,
i. e. sinus rhythm, RR intervals [33]
+ +
LF power Low frequency power, in absolute units: energy in the power
spectrum between 0.04 Hz and 0.12 Hz [33]
+ + +
HF power High frequency power, in absolute units: energy in the power
spectrum between 0.12 Hz and 0.40 Hz [33]
+
LF/(LF + HF) The ratio of low frequency power to the sum of the low
and high frequency power [33]
+ + +
During six deep breaths over one minute in supine position
EI difference The mean expiration-inspiration difference in RR intervals
over the six consecutive breaths [1, 34]
+ +
BRS A measure of baroreflex sensitivity, computed as gain,
i. e. ratio of the energy in the cross-spectrum of systolic blood
pressure and RR intervals, and the energy in the power spectrum
of the RR interval; all between 0.05 Hz and 0.15 Hz and with a
squared coherence (g 2) of 0.5 or higher [35, 36]
+ +
During an active change in position from lying to standing
RR max The difference between the mean RR interval during one min
of rest prior to standing up and the minimum RR interval within
15 s after standing up [2]
+ +
RRmax/min Maximum RR interval between 15 and 30 s after standing up
divided by minimum RR interval within 15 s after standing up [3]
+ +
SBP difference Systolic blood pressure after standing up (mean of 1.5±2 min
after standing) minus systolic blood pressure in supine position [1]
+
sufficient for processing (a poor blood pressure signal or ar-
rhythmias) or there were more than 10 % non-sinus beats in
the total number of recorded beats.
Test parameters. We computed ten measures of cardiovascular
autonomic function from the RR interval and the SBP record-
ings under the three respective conditions. Table 1 gives the
definition and the computational information of the ten mea-
sures [1±3, 33±36].
Statistical analysis. All analyses were done with SPSS 7.5 for
Windows 95. Differences between the IGT vs NGT, NDM vs
NGT and KDM vs NGT of the continuous variables were as-
sessed by analysis of variance, and the analogous differences
in proportions were tested with a Chi-squared test. Additional-
ly, for the measures of autonomic function, the variation due to
regression was tested (F-test) to assess whether a trend with
glucose tolerance was present. Because of the skewed distribu-
tions, SDNN, LF power, HF power, EI difference, BRS,
RRmax, and RRmax/min values were logarithmically trans-
formed. Geometric means were computed by back transfor-
mation of the means of logarithmically transformed values.
To estimate the effects of all putative determinants on the
test measures, multiple linear and logistic regression analysis
were done. For the linear regression analysis, logarithmic
transformation of SDNN, LF power, HF power, EI difference,
BRS, RRmax, and RRmax/min were necessary to obtain nor-
mally distributed residuals. For logistic regression the lowest
25th percentile values of the autonomic function measures in
the NGT group were taken as cut-offs. In this case the odds ra-
tio resulting from the logistic analyses can be interpreted as a
relative risk. A relative risk of 1 indicates that there is no asso-
ciation between the determinants and the occurrence of auto-
nomic dysfunction, a relative risk greater than 1 indicates a
risk factor, and a relative risk less than 1 (and ³ 0) indicates a
protective factor. Because the study group was stratified by
age, sex and glucose tolerance, these three variables were en-
tered into the regression model (the `basic' model), even
when they did not significantly contribute after other variables
were entered. Subsequently, each putative determinant was
entered separately into the `basic' model. Then four models
were constructed: the `cardiovascular', the `metabolic', the
`life-style' model, and the `full' model including all determi-
nants. As putative determinants we considered for the `cardio-
vascular' model: coronary artery disease (yes/no), cerebrovas-
cular disease (yes/no), peripheral arterial disease (yes/no), hy-
pertension on the basis of blood pressure (yes/no), and use of
antihypertensive drugs (yes/no). For the `metabolic' model:
BMI, WHR, fasting glucose, HbA1 c, fasting insulin, total cho-
lesterol, HDL cholesterol, and triglycerides (all continuous).
For the `life-style' model: physical activity (score 0±9), smok-
ing (yes/no), and use of alcohol (yes/no). The analyses were
done for the total group and also separately for each glucose
tolerance group to explore whether there were differences in
the putative determinants according to glucose tolerance. The
influence of glucose tolerance on the observed associations,
i. e. effect modification by glucose tolerance, was further tested
by adding product terms to the regression model.
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Age (years)a 63.3 ± 7.4 65.1 ± 7.0 66.2 ± 6.7 65.6 ± 6.8
Sexa male (%) 148 (51) 80 (47) 45 (47) 31 (39)
ANTHROPOMETRIC FACTORS
BMI (kg/m2) 26.0 ± 3.3 27.8 ± 3.7b 28.8 ± 4.2b 28.8 ± 5.0b
WHR 0.90 ± 0.08 0.93 ± 0.08b 0.96 ± 0.09b 0.94 ± 0.08b
CARDIOVASCULAR DISEASES
Coronary artery disease yes (%) 31 (11) 22 (13) 13 (14) 23 (29)b
Cerebrovascular disease yes (%) 12 (4) 11 (7) 8 (8) 7 (9)
Peripheral arterial disease yes (%) 53 (18) 40 (24) 27 (28)c 33 (42)b
Blood pressure (mmHg) systolic 134 ± 18 144 ± 20b 144 ± 17b 144 ± 21b
diastolic 81 ± 10 85 ± 10b 84 ± 10c 82 ± 11
Hypertension (BP) yes (%) 36 (13) 41 (24)c 22 (23)c 25 (32)b
Hypertension (WHO) yes (%) 72 (25) 78 (46)b 48 (51)b 49 (62)b
ANTIHYPERTENSIVE DRUGS
Use of antihypertensive drugs yes (%) 49 (17) 57 (34)b 32 (34)c 40 (51)b
METABOLIC FACTORS
Fasting glucose (mmol/l) 5.40 ± 0.50 6.06 ± 0.68b 8.33 ± 3.14b 10.66 ± 3.64b
HbA1c (%) 5.33 ± 0.49 5.61 ± 0.51c 6.71 ± 1.88b 7.79 ± 1.62b
Fasting insulin (pmol/l) 78 ± 34 103 ± 54b 122 ± 51b 121 ± 71b
Total cholesterol (mmol/l) 6.65 ± 1.14 6.73 ± 1.21 6.47 ± 1.23 6.54 ± 1.29
HDL cholesterol (mmol/l) 1.38 ± 0.39 1.23 ± 0.34b 1.13 ± 0.27b 1.16 ± 0.27b
Triglycerides (mmol/l) 1.49 ± 0.74 1.95 ± 1.09b 2.31 ± 1.19b 2.56 ± 2.32b
LIFESTYLE FACTORS
Physical Activity Score (0±9) 5.50 ± 1.49 5.14 ± 1.66c 5.07 ± 1.76c 4.85 ± 1.73c
Smoking yes (%) 86 (30) 40 (24) 19 (20) 20 (25)
Alcohol consumption yes (%) 207 (72) 97 (57)c 59 (62) 36 (46)b
Values are means ± SD or number of subjects and percentage between brackets. a no testing (stratified), b p < 0.001 compared to
the NGT group, c p < 0.05 compared to the NGT group
Results
Table 2 shows the characteristics of the study group in
four categories of glucose tolerance. On average, per-
sons with IGT and diabetes were older, more often
had a history of cardiovascular disease, and had an
adverse cardiovascular risk profile.
Table 3 shows the (geometric) means of the ten au-
tonomic function measures for each glucose toler-
ance group. After adjustment for age and sex, diabet-
ic patients still had statistically significant lower val-
ues for all studied measures of autonomic function,
except LF/(LF + HF) (Table 3). Persons with IGT
had significantly lower values for SDNN compared
with the NGT persons; all other measures of auto-
nomic function were also lower in the IGT group,
but this was not statistically significant. Also, after
adjustment for age and sex, a trend was observed in
the relation with glucose tolerance, except for LF/
(LF + HF) (Table 3, test for trend).
Basic regression model including each putative deter-
minant separately (the complete group). For the com-
plete group (NGT, IGT, NDM and KDM together)
age was negatively associated with most measures of
autonomic function, except for the Mean NN, LF/
(LF + HF), and SBP difference (Table 4). Sex also
appeared to be a determinant of cardiovascular auto-
nomic function: LF power, LF/(LF + HF), RRmax,
and SBP difference were lower in women. Further-
more, adjusted for age, sex, and glucose tolerance, a
consistent association ± for five of the ten measures
of autonomic function ± was found for the use of
anti-hypertensive drugs. Additional analyses showed
that the observed associations were mainly attribut-
able to the use of beta-blockers and diuretics. Less
consistent associations ± one to three of the ten mea-
sures of autonomic function ± were found for coro-
nary artery disease, cerebrovascular disease, hyper-
tension on the basis of blood pressure, BMI, WHR,
and fasting insulin.
Basic, cardiovascular, metabolic and life-style regres-
sion model (for each glucose tolerance group). Both
linear and logistic regression within the four glucose
tolerance groups showed that the observed associa-
tions in the total group were dependent on glucose
tolerance, i. e. effect-modification: the observed asso-
ciations in the total group were sometimes complete-
ly attributable to an association in only one of the
four glucose tolerance groups. Furthermore, these
findings were confirmed as being statistically signifi-
cant by adding the appropriate product terms in the
regression models (for the complete group). There
was a strong association of SDNN, LF power, HF
power, EI difference, BRS and RRmax with age in
the NGT and IGT group, whereas for the NDM and
KDM the association with age was rather weak and
statistically non-significant (Fig.1). The product
terms for SDNN, LF power, HF power and EI differ-
ence with age were statistically significant (p < 0.10).
Only for RRmax/min was the association with age
J. Gerritsen et al.: Determinants of cardiovascular autonomic function 565





































































































a Geometric means are given; b p < 0.05 compared to the NGT group, adjusted for age and sex



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































also present in the NDM and KDM groups. As as-
sessed by logistic regression, the relative risk of hav-
ing low SDNN, LF power, HF power, EI difference,
BRS or RRmax was about 1.7 to 2.8 per 10-year age
difference in the non-diabetic group. The associa-
tions with sex were only present for SDNN [relative
risk of 3.0 (1.0±8.6) for women] and RRmax [relative
risk of 4.7 (1.6±14.0) for women] in the KDM group.
Within the NGT group an association between
HbA1 c and SDNN [relative risk of 2.1 (1.1±3.9) per
%HbA1 c] and BRS [relative risk 2.2 (1.1±4.1) per %
HbA1 c] was found. The associations of measures of
cardiovascular autonomic function with cardiovascu-
lar disease were rather weak or absent in the separate
glucose tolerance groups. The associations of EI dif-
ference and RRmax with coronary artery disease as
observed in the total group were not statistically sig-
nificant in the separate glucose tolerance groups.
The observed relation of Mean NN with cerebrovas-
cular disease was present only in the NGT group [rel-
ative risk of 3.7 (1.1±12.7)], whereas in the IGT, NDM
and KDM groups the relative risks were 1.5, 1.1, and
2.2, respectively. For the EI difference an association
with cerebrovascular disease was also found in the
NGT group, relative risk of 5.1 (1.4±18.7). When tak-
ing coronary artery, cerebrovascular and peripheral
arterial disease together (any cardiovascular disease),
no substantial relations were found in the separate
glucose tolerance groups. The observed relation with
the use of anti-hypertensive drugs was, for SDNN,
[relative risk 3.1 (1.5±6.3) for users vs non-users] pre-
sent in the IGT group, for LF power [relative risk of
4.3 (2.0±9.1)] also in the IGT group, for EI difference
[relative risk of 2.1 (1.1±4.4)] in the NGT group and
for BRS [relative risk of 2.6 (1.3±5.4)] also in the
NGT group. For RRmax/min, all glucose tolerance
groups showed a relative risk of about 1.5 for users
of anti-hypertensive drugs vs non-users, but this was
not statistically significant for any of the glucose tol-
erance groups separately. The observed association
of insulin with Mean NN [relative risk of 2.7
(1.4±5.0) per 50 pmol/l] was present in the NDM
group and not present in any of the other groups (rel-
ative risk approximately 1); and for RRmax/min [rel-
ative risk of 1.5 (0.97±2.3) per 50 pmol/l] the associa-
tion was marginally statistically significant in the
KDM group and again not in any of the other groups.
The observed association in the complete group with
physical activity could not be shown in any of the glu-
cose tolerance groups separately.
The associations as observed for hypertension on
the basis of blood pressure, BMI, and WHR by linear
regression analysis in the separate glucose tolerance
groups were not statistically significant in logistic re-
gression (this was possibly due to the fact that logistic
regression is less sensitive than linear regression
when using continuous variates which show a clear
linear association). Thus, only linear regression
showed that hypertension on the basis of blood pres-
sure was statistically significantly associated with
Mean NN and HF power in the IGT group; BMI was
statistically significantly associated with LF power,
LF/(LF + HF), EI difference in the NDM group,
with RRmax/min in the IGT group, and with SBP dif-
ference in the IGT, NDM, and KDM group; WHR
was statistically significantly associated with LF pow-
er and the LF/(LF + HF) in the NGT group.
Full model (for each glucose tolerance group). Finally,
all putative determinants were entered stepwise into
one logistic regression model for each glucose toler-
ance group separately. Again, effect modification
was confirmed as being statistically significant by
adding the appropriate product terms in the regres-
sion models (for the complete group). In general, the
results were very similar to the results as reported in
the section above: (1) the same putative determinants
were marked as statistically significant, and (2) also
the size of the relative risks was about the same, indi-
cating that no major confounding between cardiovas-
cular, metabolic and life-style factors was present.
Only in the NDM and KDM groups did life-style fac-
tors, notably smoking and consumption of alcoholic
beverages, turn out to be statistically significant after
adjustment for cardiovascular disease for some of
the cardiovascular autonomic function measures.
The estimated relative risks, however, were some-
times below one and had very wide confidence inter-
vals.
J. Gerritsen et al.: Determinants of cardiovascular autonomic function 567
Fig. 1. Scatterplot of EI difference and age, stratified for glu-
cose tolerance. k, dotted line, non-diabetic subjects (normal
and impaired glucose tolerant); U, solid line, diabetic subjects
(newly-diagnosed and known diabetic). See text for statistics
Discussion
In this study group of 50- to 75-year-old subjects, age,
sex, glucose tolerance, waist-to-hip ratio, use of anti-
hypertensive drugs and insulin were associated with
cardiovascular autonomic function.
We showed that diabetes is the strongest determi-
nant of autonomic function. All autonomic measures,
except LF/(LF + HF), showed a consistent effect: in-
creased risk for low autonomic function with decreas-
ing glucose tolerance. These observations are in line
with previous studies [1, 5, 10±12]. In addition, the as-
sociation between autonomic function test measures
and the glycaemic index HbA1 c in the NGT group
has not been reported previously. A relation between
the HF power, a marker of vagal function, and serum
insulin and glucose has been reported [22, 23]. We ob-
served that in the NGT group the SDNN and BRS
were statistically significantly associated with HbA1c.
Our study confirmed that age and sex are determi-
nants of all autonomic function test measures [13±16].
This finding, however, is new for subjects aged 50 to
75 years. Furthermore, the age dependency was
mainly present in the non-diabetic group. One expla-
nation could have been the slightly younger age of
these persons compared with the diabetic subjects,
since the steepness of the relation between age and
autonomic function decreases with age. The range of
ages, however, was about the same for non-diabetic
and diabetic subjects, indicating that it was truly an
effect of diabetes (Fig.1). This effect modification
was also statistically tested in a model including age,
sex and diabetes, and the product term age x diabetes
yielded a p-value of 0.065.
Various cardiovascular diseases, including conges-
tive heart failure, myocardial infarction, and hyper-
tension have been reported to influence cardiovascu-
lar reflexes [18, 19]. In this study, the available mea-
sure of cardiovascular disease was not a strong deter-
minant among the general population. Only for cor-
onary artery disease were some associations ob-
served. It cannot be excluded, however, that more
specific measurement of subclinical cardiovascular
disease by means of, for example, cardiography,
may be associated with low autonomic function. We
did observe associations with blood pressure; howev-
er, after adjusting for cardiovascular disease and use
of antihypertensive drugs, high blood pressure
( ³ 160/95 mmHg) was not a major determinant.
Currently hypertension is defined as a blood pres-
sure over 140/90. At the time of the measurements
(1989±1992) only blood-pressure values over 160/
95 mmHg were treated, and therefore the results of
these cut-off points were presented. In addition, we
examined whether changing the definition to the
currently accepted values of 140/90 would affect our
results but this did not affect the results (data not
shown).
Also several drugs prescribed for cardiovascular
disease, including beta-blocking agents, have been
found to influence the autonomic nervous system
[21]. In our study the strongest associations were ob-
served for SDNN, LF power, LF/(LF + HF), EI dif-
ference, and RRmax/min. The latter is possibly ex-
plained by the fact that many anti-hypertensive drugs
are peripheral sympathetic vasomotor blocking
agents. These attenuate sympathetic vasomotor regu-
lation, which is one of the strongest effector mecha-
nisms of baroreflex blood pressure control. A widely
accepted theory about the origin of low frequency
(around 0.1 Hz) oscillations in BP and HR is the the-
ory of a resonating baroreflex closed control loop
caused by certain delays in vasomotor control [36,
37]. According to this theory, spontaneous or respira-
tion-related fluctuations in blood pressure and heart
rate around this resonance frequency of 0.1 Hz will
be amplified in normal conditions. In conditions of
diminished vascular resistance control, however, e.g.
due to sympathetic blocking agents, the closed loop
resonance will disappear [36]. Therefore, autonomic
function measures based on these 0.1 Hz variations,
such as LF power, LF/(LF + HF), EI difference, and
SDNN, are expected to be associated with the use
of, for instance, beta-blocking agents. On the other
hand, the BRS parameter based on the ratio of HR
to BP variations will not be influenced by vasomotor
active agents according to this resonance theory.
This is supported by our findings. The association of
cardiovascular autonomic function with the use of
anti-hypertensive drugs was stronger in the non-dia-
betic group, possibly due to the fact that diabetic sub-
jects already had low scores and the use of anti-hyper-
tensive drugs had little additional impact.
Associations between indicators of obesity and
cardiovascular autonomic dysfunction have been re-
ported [17]. We also found an association between a
high waist-to-hip ratio and low autonomic function
in the complete group, and this relationship was also
present in the glucose tolerance groups separately,
but not consistently stronger in diabetic vs non-dia-
betic subjects. It has recently been reported that au-
tonomic neuropathy (defined by a diminished E/I ra-
tio) 5 years after the diagnosis of Type II diabetes
was associated with an unfavourable metabolic risk
profile that is part of the insulin resistance syndrome
[23]. Although we did not observe an association of
autonomic function measures with lipid concentra-
tions, we did find a relation with fasting insulin, espe-
cially in diabetic subjects and both sympathetic and
parasympathetic measures were affected, as has
been reported before [38]. Since it is known that
high concentrations of insulin may not be a marker
of insulin resistance in diabetic subjects [39], a more
likely explanation for our finding could be an effect
of insulin on the activity of the sympathetic nerves:
insulin infusions (euglycaemic clamp) have been
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shown to increase plasma norepinephrine concentra-
tions (indicative of sympathetic functioning) in nor-
mal man [40]. Concomitantly with this sympathetic
activation, the parasympathetic nervous function
could be slowed down. Clearly, further studies are
needed to enlighten the pathway through which insu-
lin modulates autonomic functioning in diabetic pa-
tients.
Life-style factors have been reported to affect car-
diovascular autonomic function [25, 26]. In our study
only weak and less consistent associations were ob-
served.
Limitations of the study. Our study, being an observa-
tional epidemiologic study possibly has potential bi-
ases. Matters of concern are the selection of the study
group and possible misclassification.
Our study group consisted of an age-, sex- and glu-
cose-tolerance-stratified group of people from an un-
selected general population. Thus a large contrast in
glucose tolerance was obtained. Because no selection
with regard to other putative determinants of cardio-
vascular autonomic function was made, the contrast
in these other determinants was less optimal. This re-
duces the efficiency of the analyses. The moderate re-
producibility of the test measures may lead to mis-
classification, thus reducing the power of the study.
Test measures involving the measurement of SBP
were least reproducible (data not shown). It is not
likely, however, that the misclassification due to the
lack of reproducibility is systematic, and therefore it
will only affect the precision of the reported associa-
tions as assessed by linear regression and not the
magnitude of the coefficient. For logistic regression
the odds ratio will be underestimated due to eventual
non-systematic misclassification.
The question remains whether the observed deter-
minants are only correlates of cardiovascular auto-
nomic function or whether they are associated with
cardiovascular autonomic function in a causal way.
This cannot be decided on the basis of these cross-
sectional results. From the literature it is known that
lower values of cardiovascular autonomic function
tests per se are an important finding, since they have
prognostic value regarding cardiovascular death.
This has been shown for healthy persons [8, 9], and
for patients after a myocardial infarction [6]. Wheth-
er this relation between survival and autonomic func-
tion is dependent on glucose tolerance remains to be
investigated.
In conclusion, in a general elderly population,
measures of cardiovascular autonomic function are
consistently associated with age, sex, glucose toler-
ance, waist-to-hip ratio, use of anti-hypertensive
drugs and insulin, but less with cardiovascular disease
and not with lipid profiles. Age and use of anti-hyper-
tensive drugs were most strongly associated with car-
diovascular autonomic function test measures in the
non-diabetic population. For insulin the most pro-
nounced association was observed in subjects with di-
abetes.
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